We are using cookies This website uses cookies in order to offer you the most relevant information. By browsing this website, you accept these cookies.
We analyzed treatment results in regard to survival and local metastasis control.
2
Background: Reliable method to predict lymph node metastasis is not yet available.
3
Purpose: To review the available options of percutaneous ablation of lung metastasis.
4
Outcomes: No recurrence or metastasis occurred during 50 months after the operation.
5
However, no local recurrence or metastasis has been detected 2 months post-surgery.
1
Although uncommon, primary and metastaticneoplasms can occur in the chest wall.
2
Tumor embolism is a rare cause of stroke, occurring with primary or metastaticneoplasms of the lung.
3
The biological heterogeneity of metastaticneoplasms and the production of metastases that are resistant to therapy is the major cause of death from cancer.
1
Background: Tumor angiogenesis is essential for primary and metastatictumor growth.
2
We investigated the hypothesis that ASCs have an inhibitory effect on metastatictumor progression.
3
Bone marrow provides a unique microenvironment favoring the colonization and outgrowth of metastatictumor cells.
4
Conclusions: A metastatictumor was the only independently significant unfavorable factor for local control after SBRT.
5
Methods: Patients undergoing a clinically indicated metastatictumor biopsy were consented to the ongoing METAMORPH registry.
1
One patient had Stage II breast carcinoma; the other had metastaticdisease.
2
The patient died 1 year later due to progression of metastaticdisease.
3
The remaining five patients were believed to be free of metastaticdisease.
4
Several experimental models faithfully recapitulate many important facets of human metastaticdisease.
5
Palliative systemic treatment is the only option for patients with metastaticdisease.